New UK Biotech MiroBio Raises $34m For Autoimmune Disease Research
Company is keeping its cards close to chest on exact mechanism as it enters increasingly competitive autoimmune disease field.
Company is keeping its cards close to chest on exact mechanism as it enters increasingly competitive autoimmune disease field.